We recently published a list of Jim Cramer Discussed These 29 Stocks Ahead Of Major AI Event. In this article, we are going ...

NorthCrest Asset Manangement LLC cut its position in shares of Merck & Co., Inc. (NYSE:MRK – Free Report) by 0.1% during the ...

Merck & Co Inc (MRK) stock saw a decline, ending the day at $99.85 which represents a decrease of $-1.17 or -1.16% from the prior close of $101.02. The stock opened at $100.7 and touched a low of $98.

The stock market saw something incredible in 2024, with the “Magnificent 7” tech giants leading the charge and driving a huge ...

Drugmakers have greeted 2025, implementing price hikes for 583 products within the first two days of the new year, according ...

After an underwhelming end to last year, Micron Technology Inc. shares have been hot to start 2025, rising 18% to lead S&P ...

The Covid-19 positivity rate has also seen a rise to 7.1% this past week, versus the 5.5% figure for the past four weeks.

Novo Nordisk (NVO) and Eli Lilly's (LLY) weight loss drugs lead Evaluate Pharma’s list of best-selling drugs projected for ...

Bernstein analyst Courtney Breen maintained a Hold rating on Merck & Company (MRK – Research Report) today and set a price target of ...

As a wave of volatility has been re-introduced to the system, investors are flocking toward blue-chip companies for stability ...

Fintel reports that on January 8, 2025, Truist Securities downgraded their outlook for Merck (NYSE:MRK) from Buy to Hold.

The company did receive a $176 million grant from the U.S. Biomedical Advanced Research and Development Authority (BARDA) in ...